← All tickers

Is LXRX Worth Buying in 2026?

Lexicon Pharmaceuticals, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Lexicon Pharmaceuticals, Inc. (LXRX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.11% over 10 days); strong 1-year return of +175.9%; 3-month momentum positive (+19.2%). Concerns: declining volume on rally — weak conviction (0.72x 30d avg). Currently 24.1% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

LXRX is in a confirmed uptrend, trading above both its 50-day ($1.90) and 200-day ($1.51) moving averages. An RSI of 33.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +175.9% compares to +22.9% for SPY (beat the market by 153.1%). The current 24.1% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $27,594 today
vs. S&P 500 (SPY) — same period beat market by 153.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($1.51)
✓Above 50-day MA ($1.90)
✓RSI(14) neutral zone (30–70) — currently 33.8
✓Positive return (+175.9%)
!Within 10% of period high (−24.1%)
Period Range $1.92
$0.64 $2.53
RSI (14) 33.8
0 · OversoldOverbought · 100

Key Metrics

Price$1.92
Period Return+175.9%
Period High$2.53
Period Low$0.64
Drawdown−24.1%
MA-50$1.90
MA-200$1.51
RSI (14)33.8
Avg Volume (30d)2.8M
vs. SPYbeat by 153.1%
Return Rank#113 of 1246

Trade LXRX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers